Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Uemachi, H."'
Autor:
Matsuda, K. a, Ota, Y. a, ⁎, Uemachi, H. b, Taoda, R. a, Tsunashima, Y. a, Ban, H. a, b, Nagai, Y. a, ⁎
Publikováno v:
In Cytokine February 2025 186
Autor:
Matsuda K; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan., Ota Y; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan. Electronic address: yosuke.ota@sumitomo-pharma.co.jp., Uemachi H; Modality Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan., Taoda R; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan., Tsunashima Y; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan., Ban H; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan; Modality Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan., Nagai Y; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan. Electronic address: yasuhiro1.nagai@sumitomo-pharma.co.jp.
Publikováno v:
Cytokine [Cytokine] 2024 Dec 24; Vol. 186, pp. 156842. Date of Electronic Publication: 2024 Dec 24.
Autor:
Ota Y; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Inagaki R; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Takanashi Y; Modality Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Uemachi H; Modality Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Matsuda K; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Matsuoka M; Modality Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Taoda R; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Ohe S; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Ishitsubo Y; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Nakamura M; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Goto M; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Ban H; Oncology, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan., Nagai Y; Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka 5540022, Japan.
Publikováno v:
ACS nano [ACS Nano] 2024 Aug 27; Vol. 18 (34), pp. 23757-23772. Date of Electronic Publication: 2024 Aug 14.
Publikováno v:
In Electrochimica Acta 2001 46(15):2305-2312
Autor:
Uemachi H; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.; Oncology Laboratory for Discovery Chemistry & Technology, Sumitomo Dainippon Pharma Co., Ltd., Osaka 554-0022, Japan., Kasahara Y; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan., Tanaka K; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan., Okuda T; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan., Yoneda Y; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan., Obika S; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2021 Jun 15; Vol. 13 (6). Date of Electronic Publication: 2021 Jun 15.
Autor:
Uemachi H; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan; DSP Cancer Institute, Sumitomo Dainippon Pharma Co., Ltd., Osaka 554-0022, Japan., Kasahara Y; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan. Electronic address: y-kasahara@nibiohn.go.jp., Tanaka K; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan., Okuda T; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan., Yoneda Y; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan., Obika S; Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan; National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan.
Publikováno v:
Bioorganic chemistry [Bioorg Chem] 2020 Dec; Vol. 105, pp. 104321. Date of Electronic Publication: 2020 Oct 01.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ishida, Kenta1,2 (AUTHOR) kenta-ishida@nibiohn.go.jp, Kasahara, Yuuya1,2 (AUTHOR) h-hoshino@nibiohn.go.jp, Hoshino, Hidekazu1 (AUTHOR), Okuda, Takumi1,2 (AUTHOR), Obika, Satoshi1,2 (AUTHOR) y-kasahara@nibiohn.go.jp
Publikováno v:
Molecules. Dec2023, Vol. 28 Issue 23, p7911. 19p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.